Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
4500 participants
OBSERVATIONAL
2023-05-15
2024-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Thus, in this study, the investigators will scale up an existing trauma registry and expand use of a mHealth screening tool (triage tool). At 10 hospitals, the investigators will implement a trauma registry and mHealth tool and evaluate success in a mixed-methods study; a quantitative prospective cohort of all eligible injured patients will be followed for 6 months after discharge and an inductive qualitative study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trauma Follow-Up Prediction (Project 2: Aim 2)
NCT05464017
m-Health Supportive Care Transition Program in Improving Post-Discharged Outcomes
NCT05951335
A Culturally Sensitive Intervention for TBI Caregivers in Latin America
NCT02207803
Prehospital Severe Traumatic Brain Injury
NCT02659046
Written Versus Verbal Education for Mild Traumatic Brain Injury
NCT02252315
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A critical barrier to improved trauma outcomes in resource-limited SSA contexts is the rapid identification of patients who would benefit from further care and successful retention of these patients through treatment completion. Building on the investigators established research infrastructure in Cameroon, using an implementation science approach, the team will conduct a mixed-methods study and first expand the existing trauma registry to 10 hospitals and scale-up an mHealth, phone-based screening tool (triage tool) to identify trauma patients in Cameroon who would benefit from further formal medical care post-discharge. The second part of the study will consist of an inductive qualitative study using in-depth interviews (IDIs) with all the stakeholders: patients, ED staff, and CTR and mHealth research staff. In addition to the IDIs, the research team will also conduct a non-participant observation of the project's implementation, analyzing the behaviors of each stakeholder and the dynamics of interactions between them. The project's implementation will be assessed using domains of the Consolidated Framework for Implementation Research (CFIR) as theoretical framework. These data gathered in this aim will be triangulated to guide adaptation and optimization of the intervention in Aim 2.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aim 1 Prospective Cohort
All eligible admitted trauma patients in the trauma registry and a qualitative study of 110 in-depth interviews (IDIs).
Standard mHealth screening (triage) tool
Standard mHealth triage tool administered to eligible trauma patients by phone at 2 weeks, 1 month, 3 months, and 6 months post-hospital discharge. The mHealth triage tool is a survey that includes a 7-item questionnaire to identify their need for follow-up care.
The need for follow-up care at any of the 4 follow-ups is defined as a flagged response to ≥1 question on the 7-item screening survey.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard mHealth screening (triage) tool
Standard mHealth triage tool administered to eligible trauma patients by phone at 2 weeks, 1 month, 3 months, and 6 months post-hospital discharge. The mHealth triage tool is a survey that includes a 7-item questionnaire to identify their need for follow-up care.
The need for follow-up care at any of the 4 follow-ups is defined as a flagged response to ≥1 question on the 7-item screening survey.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Trauma patients who are formally admitted to the hospital as in-patients.
3. Trauma patients who die upon arriving to the Emergency Departments or while admitted in the hospital.
4. Trauma patients who are transferred to other health facilities.
5. Trauma patients with indications for hospital admission (based on physicians' assessments) but leave against medical advice
6. Trauma patients who are kept under observation in the Emergency Department for over 24 hours
Standard mHealth Triage Tool Eligibility: The mHealth triage tool will be administered to the subset of patients included in the trauma registry who are admitted then discharged home after treatment.
Exclusion Criteria
Although included in the WHO definition, poisonings will be excluded from the CTR as these have been extremely rare events in the CTR to date and are not typically included in trauma registries in most other contexts.
Patients who are not formally admitted and discharged within 24 hours from the Emergency Ward will be excluded.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fogarty International Center of the National Institute of Health
NIH
University of California, Los Angeles
OTHER
University of California, Berkeley
OTHER
Mefire Alain Chichom
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mefire Alain Chichom
Professor of Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alain Chichom-Mefire, MD
Role: PRINCIPAL_INVESTIGATOR
University of Buea
Catherine Juillard, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GRANT13254336
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.